ISSN: 1570-1808

Journal Home

Journal Guideline

Letters in Drug Design and Discovery Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Letters in Drug Design and Discovery is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 37. It has an SJR impact factor of 0,222 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,222.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q3) Drug Discovery (Q4) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,222

SJR Impact factor

37

H Index

172

Total Docs (Last Year)

329

Total Docs (3 years)

9716

Total Refs

360

Total Cites (3 years)

304

Citable Docs (3 years)

1.23

Cites/Doc (2 years)

56.49

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Antibiotics Q3
Current molecular pharmacology Q3
Iranian Journal of Basic Medical Sciences Q3
Biomarkers in Medicine Q3
International Journal of Peptide Research and Therapeutics Q3

Compare this journals

Aims and Scope

Best articles by citations

Molecular Basis of Agonistic Activity of ERalpha17p, a Synthetic Peptide Corresponding to a Sequence Located at the N-Terminal Part of the Estrogen Receptor alphaLigand Binding Domain

Ultrasound-Assisted 3-Component Reaction in Acetic Acid Alone: Catalyst / Promoter / Ligand Free Synthesis of Bioactive Pyrazolo[1,5-a]pyrimidines

Synthesis and Preliminary Biological Evaluation of New Heterocyclic Carboxamide Models

Copper Complexes of 8-Aminoquinoline and Uracils as Novel Aromatase Inhibitors

Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer's Disease & Molecular Modeling Studies

Theoretical Modelling of Potential Chk1 Inhibitors

Synthesis and Anticancer Activity of 7,8-dihydroxy-4-arylcoumarins

A Screening Method for Potential Anti-pancreatic Cancer Candidate Compounds Based on Hsp90-Cdc37 Interaction Model in vitro

Synthesis and Evaluation of Transdermal Permeation, Pharmacological Activity of Bornyl NSAID Esters

Recent Developments in Natural and Synthetic Drug Research for Alzheimers Disease

Novel Benzimidazole Derivatives as Selective CB2 Inverse Agonists

Activity of Amidine-containing Diphenylureas Against P. falciparum

SHOW MORE ARTICLES

Microwave-Assisted Synthesis of N-Alkylated Bibenzoimidazolyl Derivatives: Antimicrobial Studies

Synthesis, Structure-Activity Relationship (SAR) Studies on some 4-Aryl-4Hchromenes and Relationship between Lipophilicity and Antitumor Activity

Development of 1, 3 Benzothiazol-2-yl Hydrazine Derivatives Containing Semicarbazone and Thioamide Pharmacophore as Anticonvulsants

Acknowledgements to Reviewers

Identification of Pyrazole Derivative as an Antiviral Agent Against Chikungunya Through HTVS

Integrated Web-Based ab initio Modeling Platform for G-protein Coupled Receptors

Synthesis and Antimicrobial Activity of 8-Alkylpalmatine Derivatives

Pharmacophore Modeling, 3DQSAR and Structural Analysis of new Class of Potent Antimycobacterial Agents1, 3-Benzothiazin-4-Onescompounds as DprE1 Inhibitors

Targeting the Epigenome in Hematopoietic Malignancies

Editorial [Hot Topic Progress in Fighting the Multidrug Resistance of Bacteria to Treatment (Guest Editor: Mihail-Lucian Pascu)]

Preparation and Antitubercular Activities of Palindromic Hydrazinecarbothioamides and Carbonothioic Dihydrazides

Synthesis and In Vitro Biochemical Evaluation of a Series of Alkyl 6- Aminosulfonyl Naphthanoates as Potential Inhibitors of Human Placental Estrone Sulfatase (ES)